Market Cap (In SEK)
9.97 Million
Revenue (In SEK)
23 Thousand
Net Income (In SEK)
-11.67 Million
Avg. Volume
7.12 Million
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0063-0.61
- PE
- -
- EPS
- -
- Beta Value
- -2.096
- ISIN
- SE0015961826
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ms. Karin Wehlin MBA
- Employee Count
- -
- Website
- https://diagonalbio.com
- Ipo Date
- 2021-07-16
- Details
- Diagonal Bio AB operates as a biotechnology company in Sweden. It is involved in developing the Panviral platform for detecting and diagnosing small sections of pathogen genomes, such as viruses, bacteria, and fungi. The company was founded in 2020 and is headquartered in Lund, Sweden.
More Stocks
-
GENPHARMAGENPHARMASEC LIMITED
GENPHARMA
-
GATE
-
SPOISPO Networks, Inc.
SPOI
-
SLSDFSelect Sands Corp.
SLSDF
-
GGAAF
-
QBAT
-
HBIE
-
032350